One of the most pressing issues is equitable access to newly approved cancer agents. While groundbreaking therapies are continually being developed and brought to market, the reality is that not all patients, particularly those in underserved…
One of the most pressing issues is equitable access to newly approved cancer agents. While groundbreaking therapies are continually being developed and brought to market, the reality is that not all patients, particularly those in underserved…